Market Research Logo

Human Growth Hormone Market in the US 2015-2019

About Human Growth Hormone

Human growth hormone, also known as somatotropin, is a peptide with 191 amino acids and 2 sulfhydryl bridges. It is produced by the anterior pituitary, and it is required to attain normal size for children and adolescents. It also has major effects on lipid and carbohydrate metabolism of an individual. The effects of human growth hormone are mainly mediated by IGF-1 and IGF-2. There are two forms of recombinant human growth hormone approved in the market: Somatropin and Somatrem. Somatropin has 191 amino acids and Somatrem contains 192 amino acids. Growth hormone deficiency can occur either due to a damage to the pituitary or the hypothalamus gland, or can also be acquired genetically. Some of the signs of growth hormone deficiency are adiposity, short stature, and hypoglycemia.

TechNavio's analysts forecast the Human Growth Hormone market in the US to grow at a CAGR of 3.86 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Human Growth Hormone market in the US for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of the various human growth hormone drugs available in the US for the treatment of growth hormone deficiency.

TechNavio's report, the Human Growth Hormone Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the Human Growth Hormone market in the US and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Vendors

  • F. Hoffmann-La Roche
  • Merck Serono
  • Novo Nordisk
  • Pfizer
Other Prominent Vendors
  • Eli Lilly
  • Teva Pharmaceutical
  • Novartis
  • Ipsen
Market Driver
  • Demand for Human Growth Hormone
  • For a full, detailed list, view our report
Market Challenge
  • High Cost of Therapy
  • For a full, detailed list, view our report
Market Trend
  • Growing Focus on Needle-free Drug Delivery Devices
  • For a full, detailed list, view our report
Key Questions Answered in this Report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Human Growth Hormone Market in the US 2015-2019

Technavio recognizes the following companies as the key players in the Human Growth Hormone Market in the US: F. Hoffmann-La Roche Ltd., Merck Serono SA, Novo Nordisk A/S and Pfizer Inc.

Other Prominent Vendors in the market are: Eli Lilly, Ipsen, Novartis and Teva Pharmaceutical.

Commenting on the report, an analyst from Technavio’s team said: “Advances in technology have led to the development of needle-free drug delivery devices. These devices make it easy for patients to self-administer drugs and reduce the incidence of injection site reactions, therefore preventing noncompliance in the patient population.”

According to the report, human growth hormone is administered to patients with various complications such as growth hormone deficiency, Noonan and Turner syndromes, and infants who are born small for their gestational age. High incidence and prevalence of these diseases result in increased demand for human growth hormone

Further, the report states that all of the approved drugs available in the market are biologics. The development process of these biologics is expensive, thereby leading to increased pricing of these drugs. These biologics need to be kept in cold storage to retain their efficacy and avoid local reactions. Therefore, special machinery and care are required to ensure the supply of potent growth hormones.

Companies Mentioned

F. Hoffmann-La Roche , Merck Serono, Novo Nordisk , Pfizer , Eli Lilly, Teva Pharmaceutical, Novartis, Ipsen

  • Executive Summary
  • List of Abbreviations
  • Scope of the Report
    • Market Overview
    • Product Offerings
  • Market Research Methodology
    • Market Research Process
    • Research Methodology
      • Table Market Research Methodology
  • Introduction
  • Human Growth Hormone: An Overview
    • Human Growth Hormone
      • Table Structure of Human Growth Hormone
      • Table Clinical Uses of Recombinant Human Growth Hormone
    • Pharmacological Action of Human Growth Hormone
      • Table Regulation of Human Growth Hormone and its Effects
    • Therapeutic Uses of Human Growth Hormone
    • Growth Hormone Deficiency
      • Table Types of Growth Hormone Deficiency
      • Childhood-onset Growth Hormone Deficiency
      • Adult-onset Growth Hormone Deficiency
  • Market Landscape
    • Market Overview
    • Market Size and Forecast
      • Table Human Growth Hormone Market in US 2014-2019 (US$ million)
    • Five Forces Analysis
  • Buying Criteria
  • Market Growth Drivers
    • Table Drivers of Human Growth Hormone Market in US
    • Table NovoFine Needle
    • Table NordiPenMate
  • Drivers and their Impact
  • Market Challenges
    • Table Challenges in Human Growth Hormone Market
  • Impact of Drivers and Challenges
  • Market Trends
    • Table Trends in Human Growth Hormone Market
  • Trends and their Impact
  • Vendor Landscape
    • Competitive Scenario
      • Key News
      • Mergers and Acquisitions
    • Market Share Analysis 2014
      • Table Market Share of Vendors 2014
      • Table Comparison of Market Share of Major Drugs 2014 (US$ million)
      • Novo Nordisk
        • Table YoY Global Revenue and Growth Rate of Norditropin 2012-2014 (US$ million)
        • Table Dosage Strengths of FlexPro
        • Table Dosage Strengths of NordiFlex
        • Table Dosage Strengths of Norditropin NordiLet
        • Table Dosage Strengths of Nordipen
        • Table Diagrammatic Illustration of Nordipen
      • Pfizer
        • Table Genotropin Miniquick
        • Table Diagrammatic Illustration of Genotropin Miniquick
        • Table Genotropin Mixer
        • Table Parts of Genotropin Mixer
        • Table Genotropin Pen
        • Table Diagrammatic Illustration of Genotropin Pen
        • Table YoY Global Revenue and Growth Rate of Genotropin 2011-2013 (US$ million)
      • Merck Serono
        • Table YoY Global Revenue and Growth Rate of Saizen 2011-2013 (US$ million)
        • Table Diagrammatic Illustration of Click.easy
        • Table Easypod Drug Delivery Device
        • Table Diagrammatic Illustration of Cool.click 2
        • Table One.click Drug Delivery Device
        • Table Serojet Drug Delivery Device
      • F. Hoffmann-La Roche
        • Table YoY Global Revenue and Growth Rate of Nutropin 2010-2013 (US$ million)
        • Table Comparison of Global and US Revenue of Nutropin 2012 and 2013 (US$ million)
        • Table Diagrammatic Illustration of Nutropin AQ NuSpin
        • Table Nutropin AQ NuSpin 10
        • Table Nutropin AQ NuSpin 20
    • Other Prominent Vendors
  • Key Vendor Analysis
    • F. Hoffmann-La Roche Ltd.
      • Key Facts
      • Business Overview
      • Business Segmentation
        • Table Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2012 and 2013
      • Sales by Geography
        • Table F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Pharmaceuticals Division)
        • Table F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Diagnostics Division)
      • Business Strategy
      • Key Information
      • SWOT Analysis
    • Merck Serono
      • Key Facts
      • Business Overview
      • Geographical Segmentation by Revenue 2013
        • Table Merck Serono: Geographical Segmentation by Revenue 2013
      • Business Strategy
      • Recent Developments
      • SWOT Analysis
    • Novo Nordisk A/S
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2013
        • Table Novo Nordisk A/S: Business Segmentation by Revenue 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table Novo Nordisk A/S: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
      • Sales by Geography
        • Table Novo Nordisk A/S: Sales by Geography 2013
      • Business Strategy
      • Key Information
      • SWOT Analysis
    • Pfizer
      • Key Facts
      • Business Overview
      • Business Segmentation by Revenue 2013
        • Table Pfizer: Business Segmentation by Revenue 2013
      • Business Segmentation by Revenue 2012 and 2013
        • Table Pfizer: Business Segmentation by Revenue 2012 and 2013
      • Geographical Segmentation by Revenue
        • Table Pfizer: Geographical Segmentation by Revenue 2013
      • Business Strategy
      • Key Developments
      • SWOT Analysis
  • Other Reports in this Series

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report